Spotlight Is on Prostate Cancer Testing in September
During the pandemic, studies have shown many men are missing or delaying routine health screenings, including prostate cancer screenings.
Read MorePosted by Chris Wolski | Sep 2, 2021 | Prostate |
During the pandemic, studies have shown many men are missing or delaying routine health screenings, including prostate cancer screenings.
Read MorePosted by Chris Wolski | Sep 1, 2021 | Cancer |
New diagnoses of eight common types of cancer significantly declined during most of the first 13 months of the pandemic.
Read MorePosted by Chris Wolski | Aug 23, 2021 | Lung Cancer |
Researchers have developed novel artificial intelligence blood testing technology that detected over 90% of lung cancers from 800 samples.
Read MorePosted by Chris Wolski | Aug 20, 2021 | Lung Cancer |
Delfi Diagnostics’s lung cancer screening technology, which analyzes genome-wide cell-free DNA fragmentation profiles, detected 90% of cases.
Read MorePosted by Chris Wolski | Jul 16, 2021 | Colorectal, Urinalysis & Toxicology |
MIT engineers have created a diagnostic nanoparticle that can identify cancer through a urine test and act as an imaging agent, pinpointing the tumor location.
Read More